Jasper Therapeutics Stock Forecast

JSPR's stock price has decreased by -80.34% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 9 analysts with 12-month price forecasts for Jasper Therapeutics stock have an average target of 15.5, with a low estimate of 1.50 and a high estimate of 65. The average target predicts an increase of 1,567.20% from the current stock price of 0.93.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$1.50	$15.5	$7.00	$65
Change	+61.34%	+1567.2%	+652.93%	+6891.5%

Analyst Ratings

The average analyst rating for Jasper Therapeutics stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	3	3	3	3	3	3
Buy	5	5	5	5	3	3
Hold	4	4	4	4	5	5
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	12	12	12	12	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Gavin Clark-Gartner Evercore ISI Group	Evercore ISI Group	Buy Maintains $12 → $7	Buy	Maintains	$12 → $7	+652.93%	Apr 1, 2026
David Dai UBS	UBS	Hold Initiates $1.5	Hold	Initiates	$1.5	+61.34%	Mar 23, 2026
Leonid Timashev RBC Capital	RBC Capital	Hold Maintains $5 → $4	Hold	Maintains	$5 → $4	+330.25%	Nov 11, 2025
Gavin Clark-Gartner Evercore ISI Group	Evercore ISI Group	Buy Maintains $20 → $14	Buy	Maintains	$20 → $14	+1,405.86%	Sep 22, 2025
Silvan Tuerkcan JMP Securities	JMP Securities	Buy Maintains $12 → $6	Buy	Maintains	$12 → $6	+545.37%	Sep 22, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-1.93

from -3.95

EPS Next Year

-1.98

from -1.93

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-26.89	-10.33	-6.18	-4.89	-3.95	-1.93	-1.98
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	10	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.26	-0.28
Avg	-1.93	-1.98
Low	-2.91	-4.61

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.